CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

Science

/ 8
Show search box
2014-10-06
Central Europe 2020 Cooperation programme

Central Europe 2020 Cooperation programme

Central Europe 2020 Programme is aimed to support regional cooperation among nine EU Member States, mainly in the area of innovative technologies based on knowledge. In the interview for cebiotech, Mr Luca Ferrarese, Head of the Central Europe Joint Secretariat, describes the idea of the programme an... Read more
Tags europe , programme
2014-10-02
Steven Burrill announces a “life science incubator”

Steven Burrill announces a “life science incubator”

Burrill LLC is launching “Burrill Life Sciences and Healthcare Incubator”. It will allow entrepreneurs from the biotech and healthcare business to benefit from Steven Burrill’s worldwide experience and network. The Incubator will serve as a counsel, mentoring and network tool.... Read more
Tags automation in life sciences , Steven Burrill , LLC , incubator
2014-09-22 to 2014-09-23
EuropaBio Most Innovative EU Biotech SME awards

EuropaBio Most Innovative EU Biotech SME awards

EuropaBio, being the European Association for Bioindustries, has nominated five most innovative small and medium enterprises (SMEs) of the European Union, which will eventually compete for a first place on October 8th in Brussels. The annual EuropaBio award is a great opportunity for all companies to... Read more
Tags europe , innovations , award , enterprise
Hungarian researchers describing pathogens resistant to antibiotics

Hungarian researchers describing pathogens resistant to antibiotics

A growing number of antibiotic-resistant pathogens is an emerging problem of our time. Hungarian researchers have published a paper in “Nature Communications”, in which they recount how bacteria can adapt to antimicrobial drugs and reveal that in the same time microorganisms become resistant to other... Read more
Tags hungary , antibiotic resistance , pathogen
2014-09-15
Agricultural biotechnology necessary for coping with climate change

Agricultural biotechnology necessary for coping with climate change

One of the most critical global challenges that people will have to face with are future effects of climate change, which have been widely neglected for many years and are sometimes still considered as “not our problem”. Agricultural biotechnology might be an indispensable tool for coping with such c... Read more
Tags biotechnology , agriculture , gmo , climate change
2014-09-01 to 2014-09-04
Cannabidiol that is present in Cannabis sativa could be used for acne treatment

Cannabidiol that is present in Cannabis sativa could be used for acne treatment

For centuries Cannabis has been used as a medical therapy for various diseases. Recent study performed at the University of Debrecon by Hungarian researchers has revealed that cannabidiol that is present in the plant might be used for more effective treatment of acne vulgaris.... Read more
Tags cannabidiol , cannabis , acne , treatment
Collagen from fish? Yes, it is possible – interview with Dr. Olga Bukovskaya and Julia Blok

Collagen from fish? Yes, it is possible – interview with Dr. Olga Bukovskaya and Julia Blokhina

So far cattle, pig and chicken were the main sources of collagen. Because of common bovine spongiform encefalopathy (BSE) and the high production costs, the researchers were looking for other sources. Collagen is widely used in cell culture, as certain cells are adhesion-dependant (for example human ... Read more
Tags Biotechnnology , collagen type I , collagen , fish , fish , cell culture , EANOVA-COLL
2014-08-18
OTC drugs sale – how does it look like in Norway

OTC drugs sale – how does it look like in Norway

In 2012 total cost of pharmaceuticals with marketing authorization was estimated on 13.2 billion NOK, but the patients has to payed for those about 20 billion NOK. It is extremely difficult to evaluate general sale of non-prescription medicines (OTC) in Norway. Those pharmaceuticals are distributed n... Read more
Tags drugs , pharmacy , drugs sale , Norway , OTC , pharma market
2014-08-13
Why You should choose Life Science?

Why You should choose Life Science?

Technologies that would support the diagnostics, improving treatment and extended life time are the future of medicine. That is why we should support life science and invest in biotech companies. Despite the material assistance for the scientists it gives them opportunity to develop new technologies ... Read more
Tags biotechnology , biobusiness , life science , venture capital
2014-08-05 to 2014-08-06
A, B, C – the alphabet of hepatitis

A, B, C – the alphabet of hepatitis

Hepatitis A is less severe and fully curable. Hepatitis B virus may cause harsh consequences, but there is a vaccine that help the prevention. HCV still remains the most dangerous type. The disease is silent and cause harsh effects in the liver and irreversible changes in liver. The Baltic Network in... Read more
Tags hepatitis , Baltic Network , hep A virus , hep B virus , hep C virus
Connection has been made!

Connection has been made!

Brain functions remain the most fascinating but poorly understood area of human biology. Scientists from MRC laboratory in Cambridge have found a way to create and modify connections between neurons of a nematode in a highly controlled manner. Although this is just the first step, their work raises h... Read more
Tags brain , synapse , Human Connectome Project
2014-07-09
Killing triple-negative breast cancer cells with virus

Killing triple-negative breast cancer cells with virus

Triple-negative breast cancer is highly aggressive form of tumor, which cannot be efficiently treated with available therapies. Therefore, new approaches of its eradication are needed. Latest study reveals a potential of adeno-associated virus to effectively kill the cancer cells in mice.... Read more
Tags breast cancer , adeno-associated virus
2014-06-24 to 2014-06-25
Central and Eastern Europe region for execution of bio-similar and bio-equivalent studies.

Central and Eastern Europe region for execution of bio-similar and bio-equivalent studies.

The Central and Eastern Europe (CEE) region has recently become a rapidly developing sector for life sciences. During this year BioForum meeting two representatives of KCR, European Clinical Research Organization (CRO) have presented a panel session „Advantages of execution of biosimilar and bioequi... Read more
Tags bioforum , biosimilars , bioequivalent drugs , biological drugs
Green tea – a remedy for cancer?

Green tea – a remedy for cancer?

One of the most commonly worldwide consumed beverages is tea. Still black tea is consumed most frequently, however, the green tea contains majority of natural bio-active chemicals beneficial for our health. Epigallocatechin-3-gallate (EGCG) is an active compound of green tea that was used in studies ... Read more
Tags medicine , cancer , green tea , pancreas
2014-06-15
Learn from the best – the exchange of experience in the project ETTBio

Learn from the best – the exchange of experience in the project ETTBio

The ETTBio project aim is to develop an effective technology transfer in biotechnology. Ten partners from seven European countries take part in the project. Its main objective is the exchange of experience between the partners in the project.... Read more
Tags ETTBio
2014-05-26
ETTBio Project – that’s how you can learn from the others

ETTBio Project – that’s how you can learn from the others

The ETTBio (Effective Technology Transfer in Biotechnology) ... Read more
2014-04-18
Problems of scientific innovator on the todays Polish market

Problems of scientific innovator on the todays Polish market

According to the EU rankings, Poland is behind the majority of the members of this community when it comes to innovativeness of enterprises. According to some, the cause of this situation is lack of sufficient funds for research, according to others, it is a bad system of EU money distribution. Despi... Read more
Tags bioforum , innovations , bioforum 2014 , European Patent Office
2014-02-11
Stem cells in the treatment of animals

Stem cells in the treatment of animals

Biotechnology, medicine and related to them fields of science from year to year are developing more and more dynamically. Typically, all such studies are conducted for improving the state of human health or saving someone’s life. The Czech company called EponaCell used the development of science and ... Read more
Tags EponaCell , Racehorses
2013-12-13
New approach for the rheumatoid arthritis treatment – Sarilumab.

New approach for the rheumatoid arthritis treatment – Sarilumab.

A new medicine from Sanofi and Regeneron – sarilumab, the first fully-human monoclonal antibody directed against the IL-6 receptor (IL-6R). brought about positive results in the first phase 3 rheumatoid arthritis registration trial.... Read more
Tags antibodies , sarilumab , Regeneron , Sanofi , human antibodies , reumatoid , arthritis
2013-11-28
Transylvanian artificial blood made from sea worms

Transylvanian artificial blood made from sea worms

Transylvanian scientists are on the verge of inventing the artificial blood. In the Cluj-Napoca, the second most populous city in Romania the six-year experiment on mice was finished with no harmful side effects found. It was not only accepted by their bodies, but also did not caused any inflammation... Read more
Tags romania , clinical trials , blood , artificial blood , blood substitutes , preclinical